ArticleMedical & biological engineering & computing2026
C[Formula: see text]Net: A co-occurrence and consistency-aware framework for structured multi-label fundus diagnosis.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Early concurrent screening of multiple retinal pathologies is vital for preventing vision loss but poses substantial challenges for deep learning models. These include complex disease co-occurrences, severe class imbalance (long-tailed distributions), and the imperative for diagnostic logic (e.g., avoiding conflicting “Normal” and “Disease” predictions. This paper presents C[Formula: see text]Net, a unified Co-Occurrence and Consistency-Aware Network designed to address these coupled challenges simultaneously. Specifically, C[Formula: see text]Net integrates three complementary components: (1) a Co-Occurrence-Aware Supervised Contrastive Loss (CoaSupCon) that explicitly encodes positive label dependencies to capture disease correlations; (2) an Auto-Adaptive Multi-Label Focal Loss (Auto-MLFocal) that automatically learns per-class balancing and focusing parameters to mitigate long-tail imbalance; and (3) a Diagnostic Consistency Mechanism (DCM) that enforces negative dependencies and clinical logic via conflict suppression and default-to-other constraints. By unifying positive and negative dependency modeling, C[Formula: see text]Net promotes robust and clinically reliable predictions. Extensive evaluations on the ODIR-5K and MuReD benchmarks under a rigorous 5-fold cross-validation protocol demonstrate that C[Formula: see text]Net achieves consistently better performance than representative state-of-the-art methods. On ODIR-5K, it achieves a macro-average F1 (AF1) of 72.1% and a macro-average Precision (mAP) of 74.4%. On MuReD, it reaches an AF1 of 77.1% and a mAP of 80.5%. Results confirm that C[Formula: see text]Net not only improves diagnostic accuracy but also improves logical reliability, offering a unified framework for multi-label medical imaging.
Indexed as
Identifiers
42048017What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.